Eli Lilly (LLY) Gross Profit (2009 - 2026)

Eli Lilly has reported Gross Profit for 18 years, with the latest figure at $16.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 54.44% year-over-year to $16.2 billion; the trailing twelve-month figure through Mar 2026 stood at $59.8 billion (up 49.48% YoY), and the FY2025 full-year result was $54.1 billion, up 47.79% from the prior year.
• Gross Profit for Q1 2026 stood at $16.2 billion, up from $15.9 billion in the prior quarter.
• The five-year high for Gross Profit was $16.2 billion in Q1 2026, with the low at $5.1 billion in Q2 2022.
• Historically, Gross Profit has averaged $9.2 billion across 5 years, with a median of $7.6 billion in 2023.
• Annual changes were most pronounced in 2023 — Gross Profit dropped 7.05% — and 2025, when it soared 57.45%.
• Eli Lilly's Gross Profit stood at $5.8 billion in 2022, then soared by 31.49% to $7.6 billion in 2023, then surged by 47.11% to $11.1 billion in 2024, then surged by 43.04% to $15.9 billion in 2025, then rose by 1.9% to $16.2 billion in 2026.
• The last three Gross Profit figures came in at $16.2 billion (Q1 2026), $15.9 billion (Q4 2025), and $14.6 billion (Q3 2025), per Business Quant data.